Become a Franchise Trade Now BA Connect Open an Account Reactivation Segment Activation
Corporate News
Prev Next
As on Apr 23, 2021 12:00 AM Your results on : Corporate News    
Caplin Steriles receives USFDA approval for Prochlorperazine Edisylate Injection
23-Apr-2021 (13:03)
Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laboratories, has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Prochlorperazine Edisylate Injection USP, 10 mg/2 mL (5 mg/mL) Vials presentations, a generic therapeutic equivalent version of (RLD), COMPAZINE Injection, of SmithKlineBeecham Corporation, USA.

Prochlorperazine Edisylate Injection is an antiemetic and is indicated for the control of severe nausea and vomiting. According to IQVIATM (IMS Health), Prochlorperazine Edisylate Injection had US sales data of approximately $17 million for the 12-month period ending Dec 2020.

Windsor Machines to announce Quarterly Result
23-Apr-2021 (12:32)
Board of Fineotex Chemical recommends final dividend
23-Apr-2021 (12:30)
Titan Company announces incorporation of step-down subsidiary
23-Apr-2021 (12:23)
DCB Bank acquires 9.09% stake in Techfino Capital
23-Apr-2021 (11:50)
Super Sales India to conduct board meeting
23-Apr-2021 (11:55)
Tribhovandas Bhimji Zaveri to conduct board meeting
23-Apr-2021 (11:54)
Visaka Industries AGM scheduled
23-Apr-2021 (11:54)
Crown Lifters to declare Quarterly Result
23-Apr-2021 (11:54)
Rallis India to convene AGM
23-Apr-2021 (11:54)
Indian Energy Exchange cancels board meeting
23-Apr-2021 (11:25)
Capital Trade Links adjourns board meeting
23-Apr-2021 (10:53)
Board of Tata Elxsi recommends One-Time Special Dividend
23-Apr-2021 (10:41)
Board of Tata Elxsi recommends Final Dividend
23-Apr-2021 (10:41)
Board of Sasken Technologies recommends Final Dividend
23-Apr-2021 (10:41)
Equitas Small Finance Bank to declare Quarterly Result
23-Apr-2021 (10:28)
Embassy Office Parks REIT to convene board meeting
23-Apr-2021 (10:28)
Board of Rallis India recommends final dividend
23-Apr-2021 (10:28)
Alembic Pharmaceuticals receives USFDA approval for Doxepin Hydrochloride Capsules
23-Apr-2021 (10:25)
Pacheli Industrial Finance to convene board meeting
23-Apr-2021 (10:20)
Connect with us :   
Globe
About us
Our Services
Milestones
Memberships
Core Values
Investor Relations
Product & Services
Broking
Institutional Broking
PMS
Clearing Services
Distribution
Research
Depository
Trade & Products
Globe Connect Pro
Globe Trade Smart
Globe Connect Mobile/Tablet
Globe News Connect
Globe e-KYC Application
NSDL e-KYC Signer Application
Mobile App Demo
ODIN User Manual
Client Reactivation
Segment activation
Back Office
Back Office
CMS
CMS-TM
KYC/KDC Status
Mutual Fund
CAMS
RMS Policy
Helpdesk
Download Forms
Useful Links
BSE
NSE
SEBI
RBI
MCX
NCDEX
Exchange Holidays
Exchange guidelines on margin collection
Anti-Money Laundering Policy
Policies, Procedures, Rights, Obligations and RDD
Additional Policy and Procedures
Scores

Funds Payout Policy

Shortages Obligation Arising Out Of Internal Netting of Trades

Policies of Globe Commodities Limited
Guidance Note on FATCA and CRS May 2016
Right and Obligation, RDD, Guidance Note in Vernacular Language - Equity | Commodity
Additional Risk Disclosure for Trading into Commodity options
In case of any grievances pleae write to
Investor_trading@globecapital.com /  igr@globecapital.com (For Trading)     globedp@globecapital.com (For DP)    Investor_pms@globecapital.com (For PMS)     
commigr@globecapital.com (For Commodities)
Equity SEBI Registration No INZ000177137, Exchange Registration Nos : NSE TM Code - 06637, Clearing No.- M50302|BSE Clearing No: 3179|MSEI TM Code - 1004 ,Clearing No.- 4| MCX TM No: 8091,Clearing No: 8090 | NCDEX TM No:1287, Clearing No: -M51085|ICEX TM ID-2084 | SEBI Registration for DP : IN-DP-NSDL-97-99, NSDL- DP ID: IN300966, CDSL DP ID: 12020600 | SEBI Research Analysts Registration No :INH100001187 | SEBI PMS Registration No:INP000002361 CMBPID NCL CM :- IN555502
* Through subsidiary Globe Commodities Ltd. --> Commodity SEBI Regn. No. - INZ000024939, Exchange Regn. Nos. - MCX CM ID: 8550 TM ID: 10735, NCDEX CM ID: M50011 TM ID: 00012, NMCE ID: CL0111, ICEX ID: 1009, NCDXSPOT-CR-07-10011,
** Through step in subsidiary Globe Comex International DMCC --> DGCX **TM Id.1064, CM Id.3064*
"We also do Pro-Account trading in Commodity Segment.."
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
Attention Investors:
"Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your Stock Brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors"
"Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL/CDSL on the same day......................issued in the interest of investors."
"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
© 2013 Globe Capital Market Limited. All rights reserved
Designed, Developed and Content powered by CMOTS Infotech (ISO 9001:2015 Certified) Privacy Policy Disclaimer Terms and Conditions